Cabozantinib, a multi-target receptor tyrosine kinase inhibitor, decreases tumor growth and angiogenesis in a patient-derived dedifferentiated liposarcoma xenograft
Haifu Li, Agnieszka Woźniak, K Van Den Bossche, Thomas Van Looy, Jasmien Wellens, Daphne Hompes, Dana T. Aftab, Maria Dêbiec‐Rychter, Raf Sciot, Patrick Schöffski
Unknown, 2014
Abstract
An abstract is not available for this record. Please visit the publisher website for more details.